Pitavastatin calcium, vigabatrin, and romidepsin

Journal of the American Pharmacists Association

Volumn 50, Issue 4, 2010, Pages 548-551

  Hussar, Daniel A ^a   Christian, Mary Elizabeth ^b  

^a UNIVERSITY OF THE SCIENCES   (United States)

^b CVS Caremark   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; ANTINEOPLASTIC AGENT; DEPSIPEPTIDE; HISTONE DEACETYLASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PITAVASTATIN; QUINOLINE DERIVATIVE; ROMIDEPSIN; VIGABATRIN;

ADULT; ARTICLE; CUTANEOUS T CELL LYMPHOMA; DRUG APPROVAL; DRUG LABELING; HUMAN; HYPERLIPIDEMIA; INFANT; INFANTILE SPASM; SKIN TUMOR;

ADULT; ANTICONVULSANTS; ANTINEOPLASTIC AGENTS; DEPSIPEPTIDES; DRUG APPROVAL; DRUG LABELING; HISTONE DEACETYLASE INHIBITORS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERLIPIDEMIAS; INFANT; LYMPHOMA, T-CELL, CUTANEOUS; QUINOLINES; SKIN NEOPLASMS; SPASMS, INFANTILE; VIGABATRIN;

EID: 78149481151     PISSN: 15443191     EISSN: 15443450     Source Type: Journal    
DOI: 10.1331/JAPhA.2010.10530     Document Type: Short Survey

References (0)